Ultra-High Selectivity and Purity Icon
Enzyme catalysis guarantees minimal byproduct formation e.g. levulinic acid, humins, leading to high purity HMF.
Hydroxymethylfurfural HMF is a crucial platform chemical and Bio-monomers FDCA Precursor for polyethylene furanoate PEF and other furan derivatives. The main production challenge is that Chemical conversion from cellulose/fructose is non-specific, leading to side products e.g. levulinic acid and humins, which significantly reduce the yield and complicate purification. The non-specific nature of the chemical catalysis makes a green alternative necessary.
CD Biosynsis offers a highly specific enzymatic solution for HMF production: Enzymatic Synthesis: Use highly selective Dehydratases and Isomerases in a cell-free system to efficiently convert Fructose or Glucose to HMF. Using specific enzymes dramatically increases selectivity and yield. To enhance stability and recovery, we implement Solvent Engineering: Utilize biphasic reaction systems to enhance HMF yield and stability. This approach allows for continuous extraction of the product, minimizing side reactions and maximizing the final concentration.
Get a QuoteThe industrial production of HMF faces these key hurdles:
A successful solution requires high catalytic specificity under mild conditions to maximize HMF purity and stability.
CD Biosynsis utilizes enzyme-based biotransformation to optimize HMF production:
Cell-Free Enzymatic Synthesis
We deploy a cell-free system leveraging highly selective enzymes e.g. Isomerases and Dehydratases to perform the multi-step conversion of glucose/fructose to HMF with near-perfect specificity.
Enzyme Engineering
We use directed evolution or rational design to optimize the key Dehydratase enzyme for high conversion efficiency and stability under the mild, near-neutral pH conditions required for biocatalysis.
Biphasic Solvent Engineering
We utilize a biphasic reaction system aqueous/organic solvent to continuously extract the HMF product into the organic phase, minimizing its degradation and polymerization in the aqueous reaction phase.
Glucose Feedstock Utilization
We integrate high-efficiency glucose isomerase into the system, allowing the use of cheaper glucose directly, eliminating the need for separate fructose pretreatment.
This enzymatic platform ensures high yield, high purity, and superior stability of the HMF product.
Our HMF engineering service is dedicated to pursuing the following production goals:
Ultra-High Selectivity and Purity Icon
Enzyme catalysis guarantees minimal byproduct formation e.g. levulinic acid, humins, leading to high purity HMF.
Enhanced Product Stability Icon
Biphasic extraction removes HMF from the aqueous phase, preventing its degradation and polymerization.
Mild and Green Reaction Conditions Icon
Synthesis proceeds under near-neutral pH and ambient temperature, avoiding harsh acids and high energy input.
Efficient Glucose Utilization Icon
Integration of an efficient isomerase allows direct, high-yield conversion from cheap glucose feedstock.
High Throughput Cell-Free System Icon
Enzymatic systems allow for higher catalyst loading and faster reaction kinetics compared to whole-cell fermentation.
We deliver a highly efficient and selective biocatalytic solution for high-purity HMF production.
Our HMF biotransformation engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a green, high-purity HMF supply. CD Biosynsis provides customized biocatalysis and enzyme engineering solutions:
Why use a cell-free enzymatic system instead of whole-cell fermentation for HMF?
HMF is toxic to microbial cells, limiting the achievable titer in fermentation. A cell-free system uses purified enzymes, allowing for higher catalyst loading, faster reaction kinetics, and the direct use of a biphasic solvent system for product extraction, all without concerns about cell viability and toxicity.
How does the biphasic reaction system improve HMF stability?
HMF readily degrades in the aqueous, acidic conditions typically used for its formation. By adding an immiscible organic solvent, HMF is immediately extracted into the organic phase upon formation. This rapid removal from the water phase prevents its rehydration and polymerization, significantly increasing the final yield and stability.
What is the significance of using glucose isomerase?
Fructose is the direct precursor for HMF. Since glucose is cheaper and more abundant in biomass feedstocks, the integration of a highly efficient glucose isomerase allows for the initial, rate-limiting conversion of glucose to fructose in-situ, enabling the use of the most cost-effective carbon source for HMF production.
How is enzyme stability in the organic phase maintained?
We use enzyme engineering e.g. directed evolution to improve the enzyme's tolerance to the presence of organic solvent. Additionally, the enzymes are typically immobilized or function primarily in the aqueous micro-droplets within the biphasic system, minimizing direct contact with the organic solvent while still benefiting from its HMF extraction capability.
What is the estimated project timeline?
A comprehensive project involving enzyme engineering, cascade construction, and biphasic reaction optimization typically requires 20-26 weeks for final cell-free system delivery and validated high-yield bioconversion protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.